Pfizer Kicks Off Megamedia Review

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.


Achenbaum to Conduct Review of $700 Mil.-Plus Account
LOS ANGELES–Pfizer Inc. has embarked on a consolidation of its media business, launching a re-view for what will be at least a $700 million-plus account, sources said. The review follows the approval this past June of Pfizer’s $90-billion merger with Warner-Lambert, and is being led by New York-based consultant Alvin Achenbaum, according to sources.
The much-anticipated move by what is now the world’s largest drug marketer continues a remarkable run of media-only planning and buying consolidation in the U.S.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in